Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada  Sonya Cressman, PhD, MBA, Stephen.

Slides:



Advertisements
Similar presentations
William K. Evans, MD, FRCPC, Yee C
Advertisements

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors.
Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis  Ian Cromwell, MSc, Kimberly.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 
Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer  Jean-Claude Cutz, MD,
Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans  Alexander J. Ritchie, MD, Calvin Sanghera, Colin Jacobs, PhD, Wei.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Pharmacogenetic Analysis of BR
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging.
Sonya Cressman, PhD, Stuart J. Peacock, DPhil, Martin C
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
A Randomized, Phase 2 Trial of Docetaxel with or without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Relapsed.
Long-Term Outcome after En Bloc Resection of Non–Small-Cell Lung Cancer Invading the Pulmonary Sulcus and Spine  Stéphane Collaud, MD, MSc, Thomas K.
Luiz H. Araujo, MD, MSc, Philip E
Comprehensive Clinical Staging for Resectable Lung Cancer: Clinicopathological Correlations and the Role of Brain MRI  Jordyn Vernon, BHSc, Nicole Andruszkiewicz,
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated.
The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming.
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer  Suzanne Jenkins, DPhil, James C-H.
A Phase II Study of PF in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207  Paul Wheatley-Price, MBChB, MD, Quincy Chu,
Electronic Updates for JTO Readers
A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium 
A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer  Peter M. Ellis, MBBS,
Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer  Alberto Chiappori,
MA Malignancy Risk Prediction of Pulmonary Nodule in Lung Cancer Screening – Diameter Or Volumetric Measurement  R. Yuan, M. Tammemägi, A. Ritchie,
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Pulmonary Metastasectomy: A Survey of Current Practice Amongst Members of the European Society of Thoracic Surgeons  Eveline Internullo, MD, Stephen D.
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Timeliness Across the Continuum of Care in Veterans with Lung Cancer
Prevention and Management of Bone Metastases in Lung Cancer: A Review
Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist  Kitty Huang, MSc, MDCM, David A. Palma,
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Prognostic Factors for Cure, Recurrence and Long-Term Survival After Surgical Resection of Thymoma  Najib Safieddine, MD, Geoffrey Liu, MD, Kris Cuningham,
Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer  Linda.
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
Carolyn J. Shiau, MD, FRCPC, Jesse P
Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer
Clinicopathological Characteristics of Screen-Detected Lung Cancers
Early Stage Lung Cancer: Progress in the Last 40 Years
Non–Small-Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment  Gerald S. Falchook, MD,
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Rachel Benamore, MB BChir, MRCP, FRCR, Frances A
Referral Patterns for Adjuvant Chemotherapy in Patients with Completely Resected Non-small Cell Lung Cancer  Farrah Kassam, MD, Frances A. Shepherd, MD,
Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III.
P. Leland Oviatt, MD, David R
Mitotic Inhibitors Journal of Thoracic Oncology
Patients with Advanced Non–Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?  Charles Lim, MD, Mike Sung, BSc,
Mirror Mirror on the Wall, Who Is the Fairest of Them All
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in.
Racial Disparities in Health-Related Quality of Life After Lung Cancer Surgery: Findings From the Cancer Care Outcomes Research and Surveillance Consortium 
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
Adjuvant Chemotherapy for Non-small Cell Lung Cancer: Practice Patterns and Outcomes in the General Population of Ontario, Canada  Christopher M. Booth,
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Manoj P. Menon, MD, MPH, Keith D. Eaton, MD, PhD 
Genetic Changes in Squamous Cell Lung Cancer: A Review
Pharmacogenetic and Germline Prognostic Markers of Lung Cancer
Journal of Thoracic Oncology
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America 
Linda W. Martin, MD, MPH, FCCP, FACS, Gail E
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
A Review of First-Line Treatment for Small-cell Lung Cancer
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada  Sonya Cressman, PhD, MBA, Stephen Lam, MD, FRCPC, Martin C. Tammemagi, PhD, William K. Evans, MD, FRCPC, Natasha B. Leighl, MD, FRCPC, Dean A. Regier, PhD, Corneliu Bolbocean, MPP, Frances A. Shepherd, MD, FRCPC, Ming-Sound Tsao, MD, FRCPC, Daria Manos, MD, FRCPC, Geoffrey Liu, MD, FRCPC, Sukhinder Atkar-Khattra, BSc, Ian Cromwell, MSc, Michael R. Johnston, MD, FRCSC, John R. Mayo, MD, FRCPC, Annette McWilliams, MB, Christian Couture, MD, FRCPC, John C. English, MD, FRCPC, John Goffin, MD, FRCPC, David M. Hwang, MD, FRCPC, Serge Puksa, MD, FRCPC, Heidi Roberts, MD, FRCPC, Alain Tremblay, MDCM, Paul MacEachern, MD, FRCPC, Paul Burrowes, MD, FRCPC, Rick Bhatia, MD, FRCPC, Richard J. Finley, MD, FRCSC, Glenwood D. Goss, MD, FRCPC, Garth Nicholas, MD, Jean M. Seely, MD, FRCPC, Harmanjatinder S. Sekhon, MD, PhD, John Yee, MD, FRCSC, Kayvan Amjadi, MD, FRCPC, Jean-Claude Cutz, MD, Diana N. Ionescu, MD, FRCPC, Kazuhiro Yasufuku, MD, PhD, Simon Martel, MD, Kamyar Soghrati, MD, FRCPC, Don D. Sin, MD, MPH, Wan C. Tan, MD, Stefan Urbanski, MD, Zhaolin Xu, MD, Stuart J. Peacock, DPhil  Journal of Thoracic Oncology  Volume 9, Issue 10, Pages 1449-1458 (October 2014) DOI: 10.1097/JTO.0000000000000283 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Economic analysis of the Pan-Canadian Early Detection of Lung Cancer Study. NSCLC, non–small-cell lung cancer; CT, computed tomography. Journal of Thoracic Oncology 2014 9, 1449-1458DOI: (10.1097/JTO.0000000000000283) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions